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Methods 
• Used to collect data on each patients  pain 
severity, treatment data (  Dose, Fx/Dose, and 
duration), clinical features (type of cancer: 
oropharyngeal or oral, ECOG performance, and 
Karfonsky Performance Status) , pain 
assessment (intensity, score, location and 
orientation), and if the patient was having 
concurrent chemotherapy 
• Took the collected data and used it to run an 
individual sample T-test to determine if 
concurrent chemotherapy is associated with 
higher pain scores compared to RT alone.
Methods (continued)
Figure 1. Average weekly pain scores
Results (continued) Conclusion
• Overall , the results show that having concurrent 
chemotherapy or targeted therapy during 
radiotherapy does not cause a patient to have a 
higher level of pain throughout their 
radiotherapy.
• Concurrent Chemotherapy or targeted therapy 
with radiotherapy do not have a statically 
significant affect on a patients pain.
• A limitation of the study was some of the 
patients did not always take a pain survey during 
their weekly see visits, which resulted in having 
no data of their pain at certain points.
Future Directions:
• Data for this study was collected from mostly 
one source, so as more data is collected and 
tested it my cause the results to change
Background
• Head and Neck Cancer
• 8th most popular cancer in the United 
States
• Types focused on :
• Oral Cancer
• Oropharyngeal cancer
• Head and Neck Cancer usually managed with 
a multimodality treatment method[2]




• Patients who have undergone chemotherapy and 
radiotherapy will experience higher pain   
profiles through their radiation treatments.
Variables/ Measures 
• Independent Variable 
• Concurrent Chemotherapy (recorded 
in the survey as a bivariant)
• Pain Score Scale
• Recorded on a scale from 0 -10         
( 0 =  no pain , 10 = extreme pain) 
• The independent sample t-test determined 
that the p-value for these two factors <.001 
which is way below .05. (df =138)
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